G/TBT/N/CAN/497  
 
15 September 2016  
(16-4876) Page: 1/2 
Committee on Technical Barriers to Trade  Original : English/French  
 
  NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member : CANADA  
If applicable, name of local government involved  (Article 3.2 and 7.2) : 
2. Agency responsible : Health Canada  
Name and address (includi ng telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification  shall be indicated if different from above : 
Canada's SPS & TBT Notification Authority and Enquiry Point  
Global Affairs Canada  
Technical Barriers and Regulations Division (TIB)  
111 Sussex Drive, Ottawa, ON K1A 0G2  
Canada  
Telephone : (343) 203 -4273 
Fax: (613) 943 -0346 
E-mail: enquirypoint@international.gc. ca  
3. Notified under Article 2.9.2 [ X], 2.10.1 [  ], 5.6.2 [  ], 5.7.1 [  ], other : 
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading. 
ICS numbers may be provided in addition, where applicable) : Propionyl chloride; 1 -
Phenethyl-4-piperidone and its salts; 4 -Piperidone and its salts; Norfentanyl (N -phenyl -N-
piperidin -4-ylpropanamide) and its salts; 1 -Phenethylpiperidin -4-ylidenephenylamine and its 
salts; N -Phenyl -4-piperidina mine and its salts . Inorganic chemicals (ICS 71.06 0) 
5. Title, number of pages  and language(s)  of the notified document : Notice to 
Interested Parties  – Proposed Order Amending Schedule VI to the Controlled Drugs and 
Substances Act and Regulations Amending the Schedule to the Precursor Control Regulations  
to Add Chemicals Used in the Production of Fentanyl (3 pages, in English and French)   
6. Description of content : In order to address the opioid abuse crisis in Canada, Health 
Canada proposes to amend Schedule VI to the Controlled Drugs and Substances Act  
(CDSA) and the Schedule to the Precursor Control Regulations (PCR) by including in these 
Schedules six chemicals which can be used in the synthesis of fentanyl. This proposal 
would lead to further regulatory controls of these chemicals to support law enfo rcement in 
combatting illicit  fentanyl production in Canada.  
This Notice outlines Health Canada's intent with respect to its scheduling proposal and 
seeks input from the public regarding the proposed regulatory framework. Public feedback 
will be considered  by the Government during the regulatory development process.  
7. Objective and rationale , including the nature of urgent problems where 
applicable : Protection of human health  G/TBT/N/CAN/497  
 
- 2 - 
 
  8. Relevant documents : 
 News Release : http://news.gc.ca/web/article -
en.do?mthd=index&crtr.page=1&nid=1118949&_ga=1.150998777.1366195781.147
2565266  
 Canada Gazette , Part I, September 3, 2016  – Vol. 150, No.36 (pag es 2699 -2701)  
9. Proposed date of adoption : Not stated  
Proposed date of entry into force : The Notice to Interested Parties regardi ng the 
proposed scheduling was published on 3 September 2016 in Canada Gazette, Part I and the 
coming into force of the final order and regulations is anticipated in Fall 2016.   
10. Final date for comments : 8 October 2016  
11. Texts available from : Nation al enquiry point  [X] or address, telephone and fax 
number s and e mail and website address es, if available , of other body:  
The electronic version of the Notice can be downloaded on the Canada Gazette website at :  
http://www.gazette.gc.ca/rp -pr/p1/2016/2016 -09-03/html/notice -avis-eng.php#ne3   
http://www.gazette.gc.ca/rp -pr/p1/2016/2016 -09-03/html/notice -avis-fra.php#ne3   
http://www.gazette.gc.ca/rp -pr/p1/2016/2016 -09-03/pdf/g1 -15036.pdf